12-47984597-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001844.5(COL2A1):​c.1836T>C​(p.Gly612Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0632 in 1,613,810 control chromosomes in the GnomAD database, including 3,806 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.049 ( 246 hom., cov: 33)
Exomes 𝑓: 0.065 ( 3560 hom. )

Consequence

COL2A1
NM_001844.5 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.04

Publications

6 publications found
Variant links:
Genes affected
COL2A1 (HGNC:2200): (collagen type II alpha 1 chain) This gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in cartilage and the vitreous humor of the eye. Mutations in this gene are associated with achondrogenesis, chondrodysplasia, early onset familial osteoarthritis, SED congenita, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome type I, and spondyloepimetaphyseal dysplasia Strudwick type. In addition, defects in processing chondrocalcin, a calcium binding protein that is the C-propeptide of this collagen molecule, are also associated with chondrodysplasia. There are two transcripts identified for this gene. [provided by RefSeq, Jul 2008]
COL2A1 Gene-Disease associations (from GenCC):
  • achondrogenesis type II
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Kniest dysplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
  • platyspondylic dysplasia, Torrance type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • spondyloepimetaphyseal dysplasia, Strudwick type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • spondyloepiphyseal dysplasia congenita
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • spondyloepiphyseal dysplasia with metatarsal shortening
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • spondylometaphyseal dysplasia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • spondyloperipheral dysplasia
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Stickler syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Illumina, Orphanet, Genomics England PanelApp
  • Stickler syndrome, type I, nonsyndromic ocular
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • avascular necrosis of femoral head, primary, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Legg-Calve-Perthes disease
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • spondyloepiphyseal dysplasia, Stanescu type
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant rhegmatogenous retinal detachment
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dysspondyloenchondromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial avascular necrosis of femoral head
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • multiple epiphyseal dysplasia, Beighton type
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • spondylometaphyseal dysplasia, Schmidt type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • vitreoretinopathy with phalangeal epiphyseal dysplasia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 12-47984597-A-G is Benign according to our data. Variant chr12-47984597-A-G is described in ClinVar as Benign. ClinVar VariationId is 258217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0727 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL2A1NM_001844.5 linkc.1836T>C p.Gly612Gly splice_region_variant, synonymous_variant Exon 28 of 54 ENST00000380518.8 NP_001835.3 P02458-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL2A1ENST00000380518.8 linkc.1836T>C p.Gly612Gly splice_region_variant, synonymous_variant Exon 28 of 54 1 NM_001844.5 ENSP00000369889.3 P02458-2
COL2A1ENST00000337299.7 linkc.1629T>C p.Gly543Gly splice_region_variant, synonymous_variant Exon 27 of 53 1 ENSP00000338213.6 P02458-1
COL2A1ENST00000493991.5 linkn.760T>C splice_region_variant, non_coding_transcript_exon_variant Exon 11 of 37 2

Frequencies

GnomAD3 genomes
AF:
0.0493
AC:
7504
AN:
152192
Hom.:
246
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0207
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0289
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.0862
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0745
Gnomad OTH
AF:
0.0444
GnomAD2 exomes
AF:
0.0477
AC:
11965
AN:
250704
AF XY:
0.0474
show subpopulations
Gnomad AFR exome
AF:
0.0179
Gnomad AMR exome
AF:
0.0189
Gnomad ASJ exome
AF:
0.0123
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0873
Gnomad NFE exome
AF:
0.0738
Gnomad OTH exome
AF:
0.0496
GnomAD4 exome
AF:
0.0646
AC:
94408
AN:
1461500
Hom.:
3560
Cov.:
33
AF XY:
0.0630
AC XY:
45834
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.0174
AC:
583
AN:
33474
American (AMR)
AF:
0.0207
AC:
924
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0131
AC:
343
AN:
26136
East Asian (EAS)
AF:
0.000428
AC:
17
AN:
39700
South Asian (SAS)
AF:
0.0115
AC:
994
AN:
86246
European-Finnish (FIN)
AF:
0.0874
AC:
4661
AN:
53342
Middle Eastern (MID)
AF:
0.0186
AC:
107
AN:
5766
European-Non Finnish (NFE)
AF:
0.0751
AC:
83459
AN:
1111730
Other (OTH)
AF:
0.0550
AC:
3320
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
4588
9176
13764
18352
22940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2974
5948
8922
11896
14870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0493
AC:
7509
AN:
152310
Hom.:
246
Cov.:
33
AF XY:
0.0490
AC XY:
3646
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0208
AC:
866
AN:
41580
American (AMR)
AF:
0.0289
AC:
442
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3468
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5186
South Asian (SAS)
AF:
0.0133
AC:
64
AN:
4828
European-Finnish (FIN)
AF:
0.0862
AC:
915
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0744
AC:
5061
AN:
68010
Other (OTH)
AF:
0.0440
AC:
93
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
383
766
1149
1532
1915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0594
Hom.:
173
Bravo
AF:
0.0422
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0599
EpiControl
AF:
0.0633

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Stickler syndrome type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Type II Collagenopathies Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.021
DANN
Benign
0.57
PhyloP100
-1.0
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41317939; hg19: chr12-48378380; COSMIC: COSV61530805; COSMIC: COSV61530805; API